p38 MAP kinase inhibitors (Roche)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namep38 MAP kinase inhibitors (Roche)
Drug Alias NameRo-1487Ro-3391Ro-4507Ro-6145p38 MAP kinase inhibitors (Roche/CombiChem) +[20] 
ClassificationSmall molecules
Mechanisms of ActionP38 α mitogen-activated protein kinase inhibitors
TargetsP38 α mitogen-activated protein kinase
Therapy Area/IndicationsInflammationAsthmaArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Palo Alto Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDeltagen Research Laboratories LLCDupont PharmaBristol-Myers Squibb Company +[4] 
Active IndicationsN/A
Inactive IndicationsInflammationAsthmaArthritis

Other Information

ATC CodeN/A
Related LinksN/A